Saltar al contenido
Merck

Persistence of a t(11;14)-positive clone in a patient with mantle cell lymphoma for 20 years.

Clinical case reports (2017-04-12)
Yasuyuki Otsuka, Momoko Nishikori, Toshiyuki Kitano, Tomomi Oka, Takayuki Ishikawa, Hironori Haga, Akifumi Takaori-Kondo
RESUMEN

We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non-nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-SOX11 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution